Compare HKD & LAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | HKD | LAB |
|---|---|---|
| Founded | 2003 | 1999 |
| Country | France | United States |
| Employees | N/A | N/A |
| Industry | Finance: Consumer Services | Biotechnology: Laboratory Analytical Instruments |
| Sector | Finance | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 487.1M | 449.9M |
| IPO Year | 2022 | 2011 |
| Metric | HKD | LAB |
|---|---|---|
| Price | $1.36 | $1.45 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $1.35 |
| AVG Volume (30 Days) | 411.8K | ★ 2.0M |
| Earning Date | 02-27-2026 | 11-04-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $87,436,000.00 | ★ $169,737,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $11.67 | ★ N/A |
| Revenue Growth | N/A | ★ 79.77 |
| 52 Week Low | $1.33 | $0.92 |
| 52 Week High | $5.47 | $2.14 |
| Indicator | HKD | LAB |
|---|---|---|
| Relative Strength Index (RSI) | 40.06 | 48.99 |
| Support Level | $1.33 | $1.46 |
| Resistance Level | $1.43 | $1.72 |
| Average True Range (ATR) | 0.07 | 0.09 |
| MACD | -0.00 | -0.00 |
| Stochastic Oscillator | 11.55 | 8.33 |
AMTD Digital Inc along with its subsidiaries, is mainly involved in the provision of digital solutions services. Its reportable segments are digital solutions services segment, hotel operations, hospitality and VIP services segment and media and entertainment services. The company generates maximum revenue by providing financial digital solutions through its insurance brokerage services and other digital solutions services. Geographically, the company generates maximum revenue from Hong Kong and Singapore.
Standard BioTools Inc develops, manufactures, and sells technologies that help biomedical researchers in their search for developing medicines faster. Its tools provide insights into health and disease using proprietary mass cytometry and microfluidics technologies, which serve applications in proteomics and genomics, respectively. Its segments include Proteomics and Genomics. It generates maximum revenue from the Proteomics segment. Geographically, it derives a majority of its revenue from the Americas.